140 related articles for article (PubMed ID: 217561)
1. Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.
Ten Napel CH; The TH; Van Egten-Bijker J; de Gast GC; Halie MR; Langenhuysen MM
Clin Exp Immunol; 1978 Dec; 34(3):338-46. PubMed ID: 217561
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
[TBL] [Abstract][Full Text] [Related]
3. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients.
Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE
Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
[TBL] [Abstract][Full Text] [Related]
5. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
Levine PH; Reisher JI
Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
[No Abstract] [Full Text] [Related]
6. [The latent Epstein-Barr virus (EBV) activation and EBV-specific immunological abnormality in human immunodeficiency virus (HIV) infected hemophiliacs].
Matsuura A
Hokkaido Igaku Zasshi; 1989 Jul; 64(4):474-83. PubMed ID: 2555293
[TBL] [Abstract][Full Text] [Related]
7. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against herpesviruses in patients with Hodgkin's disease.
Wutzler P; Färber I; Sprössig M; Sauerbrei A; Wutke K; Höche D; Rüdiger KD; Wöckel W; Scheibner K
Arch Geschwulstforsch; 1983; 53(5):417-22. PubMed ID: 6316868
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
Masucci MG; Szigeti R; Ernberg I; Björkholm M; Mellstedt H; Henle G; Henle W; Pearson G; Masucci G; Svedmyr E; Johansson B; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4292-301. PubMed ID: 6272973
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus (EBV) in human pathology. Results of a serological investigation of a hospital population.
Dalens M; Didier J; Pris J; Enjalbert L
Biomedicine; 1973 Jul; 18(4):336-45. PubMed ID: 4139980
[No Abstract] [Full Text] [Related]
11. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
[TBL] [Abstract][Full Text] [Related]
12. Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.
Sova P; Roubalová K; Weinreb M; Hamsíková E; Kodet R; Krchnák V; Roubal J
Acta Virol; 1990 Apr; 34(2):132-8. PubMed ID: 1975974
[TBL] [Abstract][Full Text] [Related]
13. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
[TBL] [Abstract][Full Text] [Related]
16. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
17. [Epstein-Barr virus antibody pattern in lymphoproliferative disorders in children and young adults].
Nordan U; Vansover A; Gottlieb-Stematzky T
Harefuah; 1973 Nov; 85(9):395-7. PubMed ID: 4359830
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease.
Johansson B; Killander D; Holm G; Mellstedt H; Henle G; Henle W; Klein G; Söderberg G
IARC Sci Publ (1971); 1975; (11 Pt 2):237-47. PubMed ID: 191367
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
20. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
